المؤلفون: Chen Z; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. zhihong.chen@mssm.edu.; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. zhihong.chen@mssm.edu.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. zhihong.chen@mssm.edu., Soni N; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Pinero G; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Giotti B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Eddins DJ; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Medicine, Lowance Center for Human Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Lindblad KE; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ross JL; Emory University Department of Microbiology and Immunology, Emory Vaccine Center, Atlanta, GA, 30322, USA., Puigdelloses Vallcorba M; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Joshi T; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Angione A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Thomason W; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Keane A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Tsankova NM; Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Lira SA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lujambio A; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ghosn EEB; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Department of Medicine, Lowance Center for Human Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, 30322, USA., Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Hambardzumyan D; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. dolores.hambardzumyan@mssm.edu.; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. dolores.hambardzumyan@mssm.edu.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA. dolores.hambardzumyan@mssm.edu.; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. dolores.hambardzumyan@mssm.edu.

المصدر: Nature communications [Nat Commun] 2023 Apr 03; Vol. 14 (1), pp. 1839. Date of Electronic Publication: 2023 Apr 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/pathology , Carcinoma, Hepatocellular*/metabolism , Brain Neoplasms*/pathology , Liver Neoplasms*/metabolism, Mice ; Animals ; Monocytes/metabolism ; Neutrophils/metabolism ; Proto-Oncogene Proteins c-sis/metabolism ; Cell Line, Tumor

المؤلفون: Martin-Serrano MA; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Kepecs B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Torres-Martin M; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain., Bramel ER; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Haber PK; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Merritt E; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Rialdi A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Param NJ; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Maeda M; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lindblad KE; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Carter JK; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Barcena-Varela M; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mazzaferro V; General Surgery and Liver Transplantation Unit, Department of Oncology and Hemato-Oncology, University of Milan and Istituto Nazionale Tumori, IRCCS Foundation, Milano, Lombardia, Italy., Schwartz M; Department of Surgery, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Affo S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain., Schwabe RF; Department of Medicine, Columbia University, New York, New York, USA., Villanueva A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Guccione E; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Friedman SL; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lujambio A; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tocheva A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Precision Immunology Institute (PrIISM), Icahn School of Medicine at Mount Sinai, New York, New York, USA., Llovet JM; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Catalunya, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Thung SN; Department of Pathology, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tsankov AM; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sia D; Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA daniela.sia@mssm.edu.

المصدر: Gut [Gut] 2023 Apr; Vol. 72 (4), pp. 736-748. Date of Electronic Publication: 2022 May 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Bile Duct Neoplasms*/pathology , Cholangiocarcinoma*/pathology, Humans ; Animals ; Mice ; Disease Models, Animal ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Bile Ducts, Intrahepatic/metabolism ; Bile Ducts, Intrahepatic/pathology ; Tumor Microenvironment

المؤلفون: Tsai CH; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan., Chuang YM; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Li X; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Yu YR; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Tzeng SF; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland; Graduate Institute of Life Sciences, National Defense Medical Center, Taipei City, Taiwan., Teoh ST; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Di Matteo M; Laboratory of Tumor Inflammation and angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium; Laboratory of Tumor Inflammation and angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Cheng WC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Hsueh PC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Kao KC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland., Imrichova H; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Wien, Austria., Duan L; Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC, USA., Gallart-Ayala H; Metabolomics Platform, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Hsiao PW; Agricultural Biotechnology Research Center, Academia Sinica, Taipei City, Taiwan., Mazzone M; Laboratory of Tumor Inflammation and angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium; Laboratory of Tumor Inflammation and angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Ivanesevic J; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Wien, Austria., Liu X; Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC, USA., de Visser KE; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lunt SY; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA; Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, MI, USA., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA., Ho PC; Department of Oncology, University of Lausanne, Lausanne, Switzerland; Ludwig Institute of Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: ping-chih.ho@unil.ch.

المصدر: Cell metabolism [Cell Metab] 2023 Jan 03; Vol. 35 (1), pp. 118-133.e7.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101233170 Publication Model: Print Cited Medium: Internet ISSN: 1932-7420 (Electronic) Linking ISSN: 15504131 NLM ISO Abbreviation: Cell Metab Subsets: MEDLINE

مواضيع طبية MeSH: Immune Evasion* , Neoplasms*/pathology, Humans ; Interferon-gamma/metabolism ; T-Lymphocytes/metabolism ; Carcinogenesis ; Cell Transformation, Neoplastic ; Tumor Microenvironment

المؤلفون: Lindblad KE; Department of Oncological Sciences , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine , Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York , New York , USA.; The Precision Immunology Institute , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai , New York , New York , USA., Lujambio A; Department of Oncological Sciences , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine , Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York , New York , USA.; The Precision Immunology Institute , Icahn School of Medicine at Mount Sinai , New York , New York , USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai , New York , New York , USA.

المصدر: Hepatology (Baltimore, Md.) [Hepatology] 2023 Jan 01; Vol. 77 (1), pp. 6-9. Date of Electronic Publication: 2022 Jul 10.

نوع المنشور: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/diagnostic imaging , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/diagnostic imaging , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology, Humans ; Immunotherapy/methods ; Combined Modality Therapy

المؤلفون: Goswami M; National Heart Lung and Blood Institute, Bethesda, Maryland, USA.; National Cancer Institute, Bethesda, Maryland, USA., Gui G; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dillon LW; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Lindblad KE; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Thompson J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Valdez J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Kim DY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Ghannam JY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Oetjen KA; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Destefano CB; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Smith DM; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Tekleab H; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Li Y; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dagur P; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hughes T; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Marté JL; National Cancer Institute, Bethesda, Maryland, USA., Del Rivero J; National Cancer Institute, Bethesda, Maryland, USA., Klubo-Gwiezdzinksa J; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA., Gulley JL; National Cancer Institute, Bethesda, Maryland, USA., Calvo KR; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Lai C; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hourigan CS; National Heart Lung and Blood Institute, Bethesda, Maryland, USA hourigan@nih.gov.; Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Decitabine/*therapeutic use , Immunotherapy/*methods , Leukemia, Myeloid, Acute/*drug therapy, Antibodies, Monoclonal, Humanized/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Cohort Studies ; Decitabine/pharmacology ; Female ; Humans ; Male ; Pilot Projects ; Recurrence

المؤلفون: Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Ghannam J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Nosiri C; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gui G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Goswami M; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Calvo KR; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland., Lindblad KE; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Oetjen KA; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Wilkerson MD; Precision Medicine Initiative for Military Medical Research and Education, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland.; Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Soltis AR; Precision Medicine Initiative for Military Medical Research and Education, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland., Sukumar G; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland.; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Dalgard CL; Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland.; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland., Thompson J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Valdez J; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., DeStefano CB; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Lai C; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Sciambi A; Mission Bio, Inc., South San Francisco, California., Durruthy-Durruthy R; Mission Bio, Inc., South San Francisco, California., Llanso A; Mission Bio, Inc., South San Francisco, California., Gulati S; Mission Bio, Inc., South San Francisco, California., Wang S; Mission Bio, Inc., South San Francisco, California., Ooi A; Mission Bio, Inc., South San Francisco, California., Dagur PK; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., McCoy JP; Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Burr P; DNA Sequencing and Genomics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Li Y; DNA Sequencing and Genomics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. hourigan@nih.gov.

المصدر: Blood cancer discovery [Blood Cancer Discov] 2021 Jul; Vol. 2 (4), pp. 319-325. Date of Electronic Publication: 2021 May 25.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Proteogenomics*, Clonal Hematopoiesis ; Clone Cells/pathology ; Humans ; Neoplasm, Residual

المؤلفون: Qing T; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA., Jun T; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Marczyk M; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA.; Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland., Pusztai L; Breast Medical Oncology, Yale School of Medicine, New Haven, CT 06511, USA., Huang KL; Department of Genetics and Genomic Sciences, Center for Transformative Disease Modeling, Tisch Cancer Institute, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

المصدر: Cell reports. Medicine [Cell Rep Med] 2021 May 18; Vol. 2 (5), pp. 100276. Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med

مواضيع طبية MeSH: Biomarkers, Tumor/*immunology , DNA Damage/*immunology , DNA Repair/*immunology , DNA Repair-Deficiency Disorders/*immunology , Neoplasms/*genetics, Biomarkers, Tumor/genetics ; DNA Damage/genetics ; DNA Repair/genetics ; DNA Repair-Deficiency Disorders/genetics ; Genomics/methods ; Humans ; Immunity/genetics ; Immunotherapy/methods ; Mutation/genetics

المؤلفون: Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, United States.; Icahn School of Medicine at Mount Sinai, The Precision Immunology Institute, New York, NY, United States.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, United States., Ruiz de Galarreta M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, United States.; Icahn School of Medicine at Mount Sinai, The Precision Immunology Institute, New York, NY, United States., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, United States.; Icahn School of Medicine at Mount Sinai, The Precision Immunology Institute, New York, NY, United States.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, United States.

المصدر: Frontiers in immunology [Front Immunol] 2021 Apr 26; Vol. 12, pp. 642958. Date of Electronic Publication: 2021 Apr 26 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Escape*, Carcinoma, Hepatocellular/*immunology , Liver Neoplasms/*immunology, Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Humans ; Immunotherapy ; Liver Neoplasms/drug therapy ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology

المؤلفون: Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA. amaia.lujambio@mssm.edu.

المصدر: Nature medicine [Nat Med] 2021 Jan; Vol. 27 (1), pp. 25-27.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Liver Neoplasms*/therapy , T-Lymphocytes*, Humans ; Immunologic Factors ; Immunotherapy ; Macrophages

المؤلفون: Molina-Sánchez P; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Ruiz de Galarreta M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Yao MA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Lindblad KE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York., Bresnahan E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Bitterman E; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Martin TC; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Rubenstein T; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Nie K; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Golas J; Oncology R&D, Pfizer Inc, Pearl River, New York., Choudhary S; Drug Safety R&D, Pfizer Inc, Pearl River, New York., Bárcena-Varela M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Elmas A; Department of Genetics and Genomic Sciences, Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, New York., Miguela V; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Ding Y; Oncology R&D, Pfizer Inc, San Diego, California., Kan Z; Oncology R&D, Pfizer Inc, San Diego, California., Grinspan LT; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Huang KL; Drug Safety R&D, Pfizer Inc, Pearl River, New York., Parsons RE; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Shields DJ; Oncology R&D, Pfizer Inc, Pearl River, New York. Electronic address: david.shields@pfizer.com., Rollins RA; Oncology R&D, Pfizer Inc, Pearl River, New York. Electronic address: robert.rollins@pfizer.com., Lujambio A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: amaia.lujambio@mssm.edu.

المصدر: Gastroenterology [Gastroenterology] 2020 Dec; Vol. 159 (6), pp. 2203-2220.e14. Date of Electronic Publication: 2020 Aug 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Heterogeneity*, Carcinoma, Hepatocellular/*genetics , Proto-Oncogenes/*genetics, Animals ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Computational Biology ; Disease Models, Animal ; Drug Resistance, Neoplasm/genetics ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Liver Neoplasms/immunology ; Liver Neoplasms/pathology ; Male ; Mice ; Mice, Transgenic ; Tumor Escape/genetics ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology